EUCTR2007-003210-33-FI进行中（未招募）不适用
Effect of ropinirole hydrochloride in progressive myoclonic epilepsy of Unverricht–Lundborg type
Department of Neurology, Turku University Hospital0 个研究点目标入组 15 人开始时间: 2007年6月13日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) ULD diagnosed by an experienced neurologist, and confirmed with molecular diagnostics
- •2) Stimulus-activated myoclonus as the most prominent symptom of ULD
- •3) Age 18-60 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years)
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Current medicated psychiatric disorder
- •2) Previous severe head trauma
- •3) History of alcohol/substance abuse
- •4) Pregnancy or lactation
- •5) Known hypersensitivity to ropinirole hydrochloride or to other ingredients of the product
- •6) Concomitant participation in another drug study
- •7) Severe renal or hepatic insufficiency
研究者
相似试验
进行中（未招募）
不适用
A study to test the effectiveness of varying doses of ropinirole PR while taking L-dopa in patients with late stage Parkinson's disease.Advanced Parkinson's disease.MedDRA version: 16.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2011-002828-41-SKGlaxoSmithKline Research & Development Limited406
进行中（未招募）
不适用
A study to test the effectiveness of varying doses of ropinirole PR while taking L-dopa in patients with late stage Parkinson's disease.Advanced Parkinson's disease.MedDRA version: 14.1Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2011-002828-41-EEGlaxoSmithKline Research & Development Limited406
进行中（未招募）
不适用
A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage Parkinson’s Disease.Early stage Parkinson's Disease.MedDRA version: 15.1Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2011-002827-17-SKGlaxoSmithKline Research & Development Limited210
进行中（未招募）
不适用
A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage Parkinson’s Disease.EUCTR2011-002827-17-EEGlaxoSmithKline Research & Development Limited210
进行中（未招募）
不适用
Early combined prolonged release ropinirole and rasagiline therapy in newly diagnosed patients with Parkinsons disease. A prospective, randomized, parallel groups, long-term follow-up study including delayed-start design of rasagiline - Early combined ropinirole and rasagiline therapy in patients with Parkinsons diseasePatients with Parkinson`s dieseaseMedDRA version: 12.0Level: LLTClassification code 10061536Term: Parkinson's diseaseEUCTR2009-013004-31-ITIVERSITA` DEGLI STUDI DI PARMA